MLchartDataset catalogue

clofibrate

Term · Oncology and biomedicine · MLC-T-ONC-012646

An aryloxyisobutyric acid derivate with antihyperlipidemic activity. Although the exact mechanism of action has not been fully characterized, clofibrate may enhance the conversion of very-low-density lipoprotein (VLDL) to low-density lipoprotein (LDL), decreasing the production of hepatic VLDL, inhibiting cholesterol production, and increasing fecal excretion of neutral sterols.

Table 1. Record
IdentifierMLC-T-ONC-012646
FieldOncology and biomedicine
AbbreviationCFB
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012646",
  "term": "clofibrate",
  "field": "Oncology and biomedicine",
  "definition": "An aryloxyisobutyric acid derivate with antihyperlipidemic activity. Although the exact mechanism of action has not been fully characterized, clofibrate may enhance the conversion of very-low-density lipoprotein (VLDL) to low-density lipoprotein (LDL), decreasing the production of hepatic VLDL, inhibiting cholesterol production, and increasing fecal excretion of neutral sterols.",
  "abbreviation": "CFB",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/clofibrate/"
}

Record 4,981 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.